HLA-A2402 epitope peptide vaccine (Iwate Medical University)

N/A

Report date: 2024/03/01 20:05:21

Base Information

Drug NameHLA-A2402 epitope peptide vaccine (Iwate Medical University)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionCell division cycle 7-related protein kinase modulators
TargetsCell division cycle 7-related protein kinase
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIwate Medical UniversityUniversity Of Tokyo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of TokyoIwate Medical University
Active IndicationsN/A
Inactive IndicationsSolid tumoursProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A